	Kir6.2
Neonatal diabetes
Type 2 diabetes
channel
K
	neonatal diabetes
mutation
Binding
ATP
SUR
mutation alters
channels
beta cells
ATP sensitivity
Fig
ATP concentration
Kir 6
functional effects
MgATP
patients
currents
unable
clinical phenotype
neurological examination
metabolic inhibition
tolbutamide
normal developmental milestones
subunit
intracellular concentrations
functional studies
current amplitude
intrinsic
hydrophobic gate
due
vitro
increase
kg day
diabetes
heterozygous
open
concentration
insulin secretion
block
effect
normal
clinical
sulfonylurea therapy

